Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.

Journal of cancer research and clinical oncology - 1 Jun 2010

Jarmalaite Sonata, Andrekute Rasa, Scesnaite Asta, Suziedelis Kestutis, Husgafvel-Pursiainen Kirsti, Jankevicius Feliksas

Abstract excerpt

PURPOSE: Non-muscle invasive bladder cancer (BC) is a highly recurrent disease, with the first recurrences arising shortly after transurethral resection of the bladder (TURB). Topical administration of interleukin-2 (IL-2) has been shown as an effective adjuvant therapy for BC; however, predictiv...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to Calcium-Calmodulin-Dependent Protein Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death-Associated Protein Kinases

Share to Genes, p16

Share to Interleukin-2

Share to Pilot Projects

Share to Receptors, Retinoic Acid

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 19924441
DOI: 10.1007/s00432-009-0725-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19924441-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.PMID 19924441Read ↗

Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology.Semantic proximity Read ↗

Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder CancerSemantic proximity Read ↗

DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.Semantic proximity Read ↗

Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder CancerSemantic proximity Read ↗

New Approaches to Targeting Epigenetic Regulation in Bladder CancerSemantic proximity Read ↗

Promoter Hypermethylation Identifies Progression Risk in Bladder CancerSemantic proximity Read ↗

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.Semantic proximity Read ↗

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.Semantic proximity Read ↗

Regularly methylated novel pro‐apoptotic genes associated with recurrence in transitional cell carcinoma of the bladderSemantic proximity Read ↗

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Semantic proximity Read ↗

Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancerSemantic proximity Read ↗

Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.